The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of patient-reported bowel quality of life (QOL) after dose-escalated radiation therapy (RT) for prostate cancer by rectal dosimetry.
Matthew H. Stenmark
No relevant relationships to disclose
Anna S.C. Conlon
No relevant relationships to disclose
Stephanie Daignault
No relevant relationships to disclose
Michael Frederick Bassetti
No relevant relationships to disclose
Sean Vance
No relevant relationships to disclose
Robin Marsh
No relevant relationships to disclose
Dale Litzenberg
No relevant relationships to disclose
Timothy Ritter
No relevant relationships to disclose
Felix Yi-Chung Feng
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose
Martin G. Sanda
No relevant relationships to disclose
Daniel A. Hamstra
No relevant relationships to disclose